FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mylan Pharmaceuticals Levonorgestrel and Ethinyl Estradiol Tablets Recall

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0

Mylan Pharmaceuticals Inc. · Morgantown, WV

Risk level
Class III
Reported by FDA
Oct 24, 2018
Recall ID
D-0025-2019
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Levonorgestrel and Ethinyl Estradiol Tablets starting Aug 27, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0025-2019 on Oct 24, 2018. Reason: Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

Product description

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.

Lot numbers, UPCs & expiration codes

Lot # 8508F004A; Exp. 02/20

Where it was sold

Product was distributed throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0025-2019
Classification
Class III
Status
Terminated
Recall initiated
Aug 27, 2018
FDA report date
Oct 24, 2018
Quantity
5,790 cartons (526,890 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0025-2019, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
81221
Address
781 Chestnut Ridge Rd
Code information
Lot # 8508F004A; Exp. 02/20
Postal code
26505-2730
Report date
Oct 24, 2018
Product type
Drugs
Recall number
D-0025-2019
Classification
Class III
Recalling firm
Mylan Pharmaceuticals Inc.
Product quantity
5,790 cartons (526,890 tablets)
Termination date
Jul 26, 2019
Reason for recall
Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.
Distribution pattern
Product was distributed throughout the United States.
Recall initiation date
Aug 27, 2018
Initial firm notification
Letter
Center classification date
Oct 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0025-2019, published Oct 24, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls